A pharmacy in The Hague creates its own medicine for seven sick children in India because the manufacturer is asking an unaffordable price for it.

A pharmacy in The Hague has produced tiratricol, a crucial medication for seven sick children in India, after the manufacturer raised prices excessively. The pharmacy created the drug at a fraction of the cost, making it accessible for families who could not afford the original price set by Egetis. The initiative was sparked by the plight of a young boy suffering from a rare genetic disorder, leading to a broader effort to help other affected children. The Dutch pharmacy received prescriptions from Indian doctors and obtained government approval for importation. This case highlights ongoing issues with pharmaceutical pricing and access to essential medications.